Would lowering ANDA costs boost domestic generic drug production?
Mark Cuban recently told Healthcare Brew the costs “kill the economics” for drugmakers like his.
Maia is a Minnesota-based senior reporter and founding reporter of Healthcare Brew, where she covers the pharmacy industry, women’s health, digital health, and how venture capital is shaping healthcare. She previously worked as a fellow covering the aerospace industry at Insider, as well as a healthcare reporter for Becker's Hospital Review. She has won an award from the Society of Professional Journalists for her work.
Mark Cuban recently told Healthcare Brew the costs “kill the economics” for drugmakers like his.
Many are testing AI tools without setting clear goals for their use, according to two health AI experts.
Cheaper options may grant many more patients worldwide access to GLP-1s.
We may be getting closer to the first FDA-approved psychedelic treatment.
The health system is one of the only freestanding comprehensive cancer centers in the US.
Because historically it hasn’t been the most fun—or efficient—part of the healthcare system.
King started the company while still in college.
Alternatives are enticing, but change has proven to be difficult.
Several of the show’s plotlines came directly from Sylvia Owusu-Ansah’s lived experiences.
An FTC official told us the task force will focus on making healthcare more affordable.